The epitranscriptome landscape of small noncodingRNAsin stem cells

被引:11
作者
McElhinney, James M. W. R. [1 ]
Hasan, Ayesha [1 ]
Sajini, Abdulrahim A. [1 ]
机构
[1] Khalifa Univ Sci & Technol, Dept Biomed Engn, POB 127788, Abu Dhabi, U Arab Emirates
关键词
adult stem cells; cancer stem cells; epigenetics; epitranscriptome; microRNAs; noncoding RNAs; PIWI-INTERACTING RNAS; HEMATOPOIETIC STEM; MESSENGER-RNA; LET-7; MIRNAS; SELF-RENEWAL; CANCER; METHYLTRANSFERASE; METHYLATION; M(6)A; N-6-METHYLADENOSINE;
D O I
10.1002/stem.3233
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Stem cells (SCs) are unique cells that have an inherent ability to self-renew or differentiate. Both fate decisions are strongly regulated at the molecular level via intricate signaling pathways. The regulation of signaling networks promoting self-renewal or differentiation was thought to be largely governed by the action of transcription factors. However, small noncoding RNAs (ncRNAs), such as vault RNAs, and their post-transcriptional modifications (the epitranscriptome) have emerged as additional regulatory layers with essential roles in SC fate decisions. RNA post-transcriptional modifications often modulate RNA stability, splicing, processing, recognition, and translation. Furthermore, modifications on small ncRNAs allow for dual regulation of RNA activity, at both the level of biogenesis and RNA-mediated actions. RNA post-transcriptional modifications act through structural alterations and specialized RNA-binding proteins (RBPs) called writers, readers, and erasers. It is through SC-context RBPs that the epitranscriptome coordinates specific functional roles. Small ncRNA post-transcriptional modifications are today exploited by different mechanisms to facilitate SC translational studies. One mechanism readily being studied is identifying how SC-specific RBPs of small ncRNAs regulate fate decisions. Another common practice of using the epitranscriptome for regenerative applications is using natural occurring post-transcriptional modifications on synthetic RNA to generate induced pluripotent SCs. Here, we review exciting insights how small ncRNA post-transcriptional modifications control SC fate decisions in development and disease. We hope by illustrating how essential the epitranscriptome and their associated proteome are in SCs, they would be considered as novel tools to propagate SCs for regenerative medicine.
引用
收藏
页码:1216 / 1228
页数:13
相关论文
共 50 条
  • [31] Epigenetic Modifications of Stem Cells A Paradigm for the Control of Cardiac Progenitor Cells
    Zhou, Yonggang
    Kim, Johnny
    Yuan, Xuejun
    Braun, Thomas
    CIRCULATION RESEARCH, 2011, 109 (09) : 1067 - 1081
  • [32] Small molecules for stem cells
    Kochegarov, Andrei
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (03) : 275 - 281
  • [33] Neuroblastoma stem cells - mechanisms of chemoresistance and histonedeacetylase inhibitors
    Khalil, M. A.
    Hrabeta, J.
    Cipro, S.
    Stiborova, M.
    Vicha, A.
    Eckschlager, T.
    NEOPLASMA, 2012, 59 (06) : 737 - 746
  • [34] The NF-κB Pathway and Cancer Stem Cells
    Rinkenbaugh, Amanda L.
    Baldwin, Albert S.
    CELLS, 2016, 5 (02)
  • [35] Resetting the epigenome: Methylation dynamics in cancer stem cells
    Roy, Aiendrila
    Padhi, Swati Shree
    Khyriem, Ibakordor
    Nikose, Saket
    Sankar, S. H. Harsha
    Bharathavikru, Ruthrotha Selvi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [36] New insights in oncology: Epigenetics and cancer stem cells
    Krutovskikh, V.
    Partensky, C.
    CANCER RADIOTHERAPIE, 2011, 15 (08): : 716 - 722
  • [37] Cancer stem cells
    Schwarz-Cruz-y-Celis, Angela
    Melendez-Zajgla, Jorge
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 (02): : 179 - 186
  • [38] tModBase: deciphering the landscape of tRNA modifications and their dynamic changes from epitranscriptome data
    Lei, Hao-Tian
    Wang, Zhang-Hao
    Li, Bin
    Sun, Yang
    Mei, Shi-Qiang
    Yang, Jian-Hua
    Qu, Liang-Hu
    Zheng, Ling-Ling
    NUCLEIC ACIDS RESEARCH, 2023, 51 (D1) : D315 - D327
  • [39] Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas
    Menendez, Sofia T.
    Gallego, Borja
    Murillo, Dzohara
    Rodriguez, Aida
    Rodriguez, Rene
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [40] Cancer stem cells niche: A target for novel cancer therapeutics
    Yi, Shan-Yong
    Hao, Yi-Bin
    Nan, Ke-Jun
    Fan, Tian-Li
    CANCER TREATMENT REVIEWS, 2013, 39 (03) : 290 - 296